US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
EPX Ltd. (EPX) 銘柄情報

EPX Ltd. (EPX)

0.165

-0.005

(-2.94%)

終了 7月10日 3:00PM

EPX Ltd. (EPX) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

0.165

( -2.94% )

買値

0.165

売値

0.17

出来高

48,258

平均取引量 (3 か月)

AUD 60,913

財務取引量

-

0.165 日の範囲 0.165

0.019 52 週間の範囲 0.28

時価総額

企業価値

12.702M

前日終値

0.17

始値

0.165

時刻

最終取引時間

VWAP

-

歳入

15.6M

純利益

-6.7M

発行済株式数

86,476,328

浮動株比率 (%)

49.89%

機関投資家保有比率 (%)

19.66%

配当利回り

PER

-1.75

株価売上高倍率 (PSR)

0.94

1 株当たり利益 (EPS)

-0.1

ベータ

1.09

EPX Limited provides building energy management solutions for commercial real estate in Australia, Asia, the United Kingdom, and the Middle East. The company offers EDGE cloud data platform, a managed platform that streamlines data collection from submeters, IoT sensors, and building management syst... EPX Limited provides building energy management solutions for commercial real estate in Australia, Asia, the United Kingdom, and the Middle East. The company offers EDGE cloud data platform, a managed platform that streamlines data collection from submeters, IoT sensors, and building management systems (BMS), which identifies opportunities to reduce energy, water, and waste consumption within the building by collecting, processing, and analyzing sets of data per year. Its EDGE platform products include EDGE Essential, EDGE Commercial, EDGE Insight, EDGE Insight+, EDGE Industrial, and EDGE Certifi. The company also provides EDGE Capabilities, such as capture, aggregate, analyze, and optimize. It offers its solutions for commercial offices, hospitals, hotels, retail, shopping centers, healthcare, and hospitals sectors. The company was formerly known as EP&T Global Limited and changed its name to EPX Limited in June 2025. EPX Limited was founded in 1993 and is based in North Sydney, Australia. 詳細を表示

セクター

Technology

業界

Software & It Services

ウェブサイト

www.eptglobal.com

本社

North Sydney, Australia

設立

1993

EPX Ltd. is listed in the Technology sector of the オーストラリア証券取引所 with ticker EPX. The last closing price for EPX was AUD0.17. Over the last year, EPX shares have traded in a share price range of AUD 0.019 to AUD 0.28.

EPX currently has 86,476,328 shares in issue. The market capitalisation of EPX is AUD14.27 million. EPX has a price to earnings ratio (PE ratio) of -1.75.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.005	-2.94117647059	0.17	0.17	0.165	52985	0.17	DE
4	-0.005	-2.94117647059	0.17	0.19	0.15	51121	0.16770499	DE
12	-0.115	-41.0714285714	0.28	0.28	0.15	58238	0.20065859	DE
26	-0.095	-36.5384615385	0.26	0.28	0.15	49634	0.21758595	DE
52	0.142	617.391304348	0.023	0.28	0.019	190737	0.06025555	DE
156	0.14	560	0.025	0.28	0.017	227058	0.03660324	DE
260	-0.045	-21.4285714286	0.21	0.28	0.017	233877	0.05062592	DE

EPX - Frequently Asked Questions (FAQ)

What is the current EPX Ltd. share price?

The current share price of EPX Ltd. is AUD 0.165

How many EPX Ltd. shares are in issue?

EPX Ltd. has 86,476,328 shares in issue

What is the market cap of EPX Ltd.?

The market capitalisation of EPX Ltd. is AUD 14.27M

What is the 1 year trading range for EPX Ltd. share price?

EPX Ltd. has traded in the range of AUD 0.019 to AUD 0.28 during the past year

What is the PE ratio of EPX Ltd.?

The price to earnings ratio of EPX Ltd. is -1.75

What is the cash to sales ratio of EPX Ltd.?

The cash to sales ratio of EPX Ltd. is 0.94

What is the registered address of EPX Ltd.?

The registered address for EPX Ltd. is 213 Miller Street, North Sydney, New South Wales, 2060

What is the EPX Ltd. website address?

The website address for EPX Ltd. is www.eptglobal.com

Which industry sector does EPX Ltd. operate in?

EPX Ltd. operates in the Software & IT Services sector

Gamco

This is an older version of the Amazon/InterDigital arbitration news (with my highlights) that I don't believe was posted previously:

Amazon and InterDigital will settle their FRAND dispute through arbitration
Rumours of an agreement in the streaming dispute between InterDigita

Monksdream

Monksdream 3分前

HAO, there it goes

rizona

Answer my question. How do you know the granular details of the article if, as you say, you don't have access?

Tantalos

Tantalos 6分前

The product don’t lie, I use it, FDA approved, Let’s see how Government Defense contracts works out? Major marketing advertising which ActiPatch really never had.

prototype_101

prototype_101 8分前

DJ thanks for posting this Lebby presentation "Foundry Based Polymer Optical Modulators", it is a very comprehensive presentation that shows just how spot on Lebby was is seeing the future path to LWLG adoption in the commercial world, just look at

Slide 19 to see where Lebby was maki

Monksdream

Monksdream 9分前

ZBAO About

Zhibao Technology, Inc. is a holding company, which engages in the provision of digital insurance solutions. It offers insurance brokerage and managing general underwriting services. The company was founded by Bo Tao Ma on January 11, 2023 and is headquartered in Shanghai,

FrostyIsland3

FrostyIsland3 9分前

Theorysuit, can you explain why you believe that the MHRA has already rejected the DCVax-L MAA?

Jake731

Jake731 9分前

Good morning all..

FRIDAY 🪻 FRIDAY 🪻

VuMe Live 😎😎😎

FrostyIsland3

FrostyIsland3 11分前

The central issue we need to resolve is whether the MHRA has rejected the DCVax-L MAA and NWBO is failing to disclose.

The MHRA will ultimately approve the DCVax-L MAA if there is no CHM letter. I have no confidence that Linda Powers would disclose the existence of a CHM letter if on

funnytimes2

funnytimes2 12分前

This is from 2019.

TMaga

Where are all the buy backs of shares they lied about for years.

train21

train21 12分前

$gtvh and Leal has posted when he was the ceo that all the legacy debt was cleared up
she or he lied ? or both ?

ORCA

$CYBL WILL LOSE 90% AFTER THEY DO A R/S,THEY ARE PLANNING A R/S AND THAT IS WHY THEY DO NOT MENTION ANYTHING ABOUT NOT DOING A R/S ON X.WHEN I ASKED THEM.
A SELL SHORT WILL BE GIVEN THE DAY OF THE R/S AND YOU WILL NOT BELIEVE HOW FAST IT WILL LOSE 90%.

mmayr

Yesterday's Result (Quarterfinals) of the FIFA World Cup Soccer Games

Yesterday, France advanced to the semifinals after defeating Morocco 2–0 at Boston Stadium.

France 2 – 0 Morocco

Goals: Kylian Mbappé (60'), Ousmane Dembélé (66')

Today'

theorysuit

theorysuit 16分前

This is exactly what is happening and I have been saying this. But the paid pump crew keeps making excuses and saying everything is fine. Really 2.6 years later? Lmfao.

ORCA

R/S =DEATH.TAKE IT TO THE BANK.
IF THEY DO A R/S NOW WE ARE FD.LOOK AT WHAT HAPPENED TO $SRXH ON THE R/S IT WAS $15.00 TO LOW OF .96 THE DAY OF THE R/S.THEN NEWS HIT AND WENT TO $3.00.SO FOR THE PEOPLE TO GET THEIR MONEY BACK BEFORE THE R/S THEY NEED $8.00 TO $15.00 PER SHARE.NOW IT IS $2.4

Z06 MAN

Z06 MAN 19分前

Thanks for sharing… Regurgitated info from other interviews. All forward looking… Nothing new….The company is buying time, why? No good
News to report?

SovereignNinja5

SovereignNinja5 21分前

Roon, thanks for filling in a blank for me. Stay focused on Innovia and fact check this. But I think $300 million was made and Sarissa is unwinding the positions for optics and why he has Goldman and Barclays as bankers. The settlement required it. April 26 was a deadline.
Subject: Sarissa,

CryptoRain

CryptoRain 21分前

Well well 😊. Who’s your lion now..

TMaga

GlucoGuard Receives $43 Million Enterprise Valuation From Prominent CFA Led Harbinger Research
November 04 2025 - 9:00AM
Newsfile
Alert
Print
Share On Facebook

ADHC Files July 31st, 2025 Annual Disclosure

Del Mar, California--(Newsfil

US Market News

US Market News 26分前

InMode Confirms Receipt of Unsolicited ProposalJuly 10, 2026 7:00 AM
PR Newswire (US) class="legendSpanClass"YOKNEAM, Israel, class="legendSpanClass"July 10, 2026 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD) (the "Company") confirmed that

US Market News

US Market News 26分前

Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)July 10, 2026 7:01 AM
Business Wire Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to dev

Sagon Resources

European Financial Stabi...

Intelgenx Technologies

Federal bond until 15/08...

Jinxin Fertility

Antin Infrastructure Par...

0% until 3jan2028 0% unt...

First Trust Japan Alpha ...

Forum Energy Metals

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。